{"id":1075,"date":"2024-02-08T09:37:00","date_gmt":"2024-02-08T09:37:00","guid":{"rendered":"https:\/\/cannara24.cryodragon.pro\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/"},"modified":"2024-11-16T21:36:17","modified_gmt":"2024-11-16T21:36:17","slug":"nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir","status":"publish","type":"post","link":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/","title":{"rendered":"Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d&rsquo;avenir"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Nicholas Sosiak, directeur financier de Cannara Biotech Inc., s&rsquo;est joint \u00e0 Steve Darling de Proactive pour fournir des informations pr\u00e9cieuses sur la r\u00e9ussite de l&rsquo;entreprise dans l&rsquo;industrie du cannabis.<\/p>\n\n<p class=\"wp-block-paragraph\">M. Sosiak a \u00e9voqu\u00e9 les acquisitions strat\u00e9giques de l&rsquo;entreprise, notamment l&rsquo;achat d&rsquo;une usine de cannabis d&rsquo;un million de pieds carr\u00e9s pour 27 millions de dollars, soit un prix nettement inf\u00e9rieur \u00e0 son co\u00fbt initial. Cannara Biotech Inc. a \u00e9galement d\u00e9velopp\u00e9 trois marques internes : Tribal, Nugs et Orchid CBD, chacune visant des niches de march\u00e9 sp\u00e9cifiques. L&rsquo;entreprise met l&rsquo;accent sur la coh\u00e9rence et la qualit\u00e9 afin de fid\u00e9liser les consommateurs \u00e0 la marque.<\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nicholas Sosiak, directeur financier de Cannara Biotech Inc., s&rsquo;est joint \u00e0 Steve Darling de Proactive pour fournir des informations pr\u00e9cieuses sur la r\u00e9ussite de l&rsquo;entreprise dans l&rsquo;industrie du cannabis. M. Sosiak a \u00e9voqu\u00e9 les acquisitions strat\u00e9giques de l&rsquo;entreprise, notamment l&rsquo;achat d&rsquo;une usine de cannabis d&rsquo;un million de pieds carr\u00e9s pour 27 millions de dollars, soit un prix nettement inf\u00e9rieur \u00e0 son co\u00fbt initial. Cannara Biotech Inc. a \u00e9galement d\u00e9velopp\u00e9 trois marques internes : Tribal, Nugs et Orchid CBD, chacune visant des niches de march\u00e9 sp\u00e9cifiques. L&rsquo;entreprise met l&rsquo;accent sur la coh\u00e9rence et la qualit\u00e9 afin de fid\u00e9liser les consommateurs \u00e0 la marque.<\/p>\n","protected":false},"author":1,"featured_media":1133,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":"","_wpscp_schedule_draft_date":"","_wpscp_schedule_republish_date":"","_wpscppro_advance_schedule":false,"_wpscppro_advance_schedule_date":"","_wpscppro_dont_share_socialmedia":false,"_wpscppro_custom_social_share_image":0,"_facebook_share_type":"","_twitter_share_type":"","_linkedin_share_type":"","_pinterest_share_type":"","_linkedin_share_type_page":"","_instagram_share_type":"","_medium_share_type":"","_threads_share_type":"","_google_business_share_type":"","_bluesky_share_type":"","_mastodon_share_type":"","_selected_social_profile":[],"_wpsp_enable_custom_social_template":false,"_wpsp_social_scheduling":{"enabled":false,"datetime":null,"platforms":[],"status":"template_only","dateOption":"today","timeOption":"now","customDays":"","customHours":"","customDate":"","customTime":"","schedulingType":"absolute"},"_wpsp_active_default_template":true},"categories":[16],"tags":[],"class_list":["post-1075","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d&#039;avenir - Cannara Biotech<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d&#039;avenir - Cannara Biotech\" \/>\n<meta property=\"og:description\" content=\"Nicholas Sosiak, directeur financier de Cannara Biotech Inc., s&#039;est joint \u00e0 Steve Darling de Proactive pour fournir des informations pr\u00e9cieuses sur la r\u00e9ussite de l&#039;entreprise dans l&#039;industrie du cannabis. M. Sosiak a \u00e9voqu\u00e9 les acquisitions strat\u00e9giques de l&#039;entreprise, notamment l&#039;achat d&#039;une usine de cannabis d&#039;un million de pieds carr\u00e9s pour 27 millions de dollars, soit un prix nettement inf\u00e9rieur \u00e0 son co\u00fbt initial. Cannara Biotech Inc. a \u00e9galement d\u00e9velopp\u00e9 trois marques internes : Tribal, Nugs et Orchid CBD, chacune visant des niches de march\u00e9 sp\u00e9cifiques. L&#039;entreprise met l&#039;accent sur la coh\u00e9rence et la qualit\u00e9 afin de fid\u00e9liser les consommateurs \u00e0 la marque.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/\" \/>\n<meta property=\"og:site_name\" content=\"Cannara Biotech\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-08T09:37:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-16T21:36:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/11\/CannaraPress_Newsdirect-100.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cannaraadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cannaraadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/\"},\"author\":{\"name\":\"cannaraadmin\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/person\\\/3aaaabd90bd805cac77b57ae47bf0f91\"},\"headline\":\"Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d&rsquo;avenir\",\"datePublished\":\"2024-02-08T09:37:00+00:00\",\"dateModified\":\"2024-11-16T21:36:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/\"},\"wordCount\":136,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cannara.ca\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/CannaraPress_Newsdirect-100.jpg\",\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/\",\"name\":\"Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d'avenir - Cannara Biotech\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cannara.ca\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/CannaraPress_Newsdirect-100.jpg\",\"datePublished\":\"2024-02-08T09:37:00+00:00\",\"dateModified\":\"2024-11-16T21:36:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/CannaraPress_Newsdirect-100.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cannara.ca\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/CannaraPress_Newsdirect-100.jpg\",\"width\":1000,\"height\":563},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2024\\\/02\\\/08\\\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d&#8217;avenir\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/\",\"name\":\"Cannara Biotech\",\"description\":\"Premium Quality Cannabis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#organization\",\"name\":\"Cannara Biotech\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Cannara_LogoV1_500pxT.png\",\"contentUrl\":\"https:\\\/\\\/www.cannara.ca\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Cannara_LogoV1_500pxT.png\",\"width\":500,\"height\":135,\"caption\":\"Cannara Biotech\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/person\\\/3aaaabd90bd805cac77b57ae47bf0f91\",\"name\":\"cannaraadmin\",\"sameAs\":[\"https:\\\/\\\/www.cannara.ca\"],\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/author\\\/cannaraadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d'avenir - Cannara Biotech","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/","og_locale":"fr_FR","og_type":"article","og_title":"Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d'avenir - Cannara Biotech","og_description":"Nicholas Sosiak, directeur financier de Cannara Biotech Inc., s'est joint \u00e0 Steve Darling de Proactive pour fournir des informations pr\u00e9cieuses sur la r\u00e9ussite de l'entreprise dans l'industrie du cannabis. M. Sosiak a \u00e9voqu\u00e9 les acquisitions strat\u00e9giques de l'entreprise, notamment l'achat d'une usine de cannabis d'un million de pieds carr\u00e9s pour 27 millions de dollars, soit un prix nettement inf\u00e9rieur \u00e0 son co\u00fbt initial. Cannara Biotech Inc. a \u00e9galement d\u00e9velopp\u00e9 trois marques internes : Tribal, Nugs et Orchid CBD, chacune visant des niches de march\u00e9 sp\u00e9cifiques. L'entreprise met l'accent sur la coh\u00e9rence et la qualit\u00e9 afin de fid\u00e9liser les consommateurs \u00e0 la marque.","og_url":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/","og_site_name":"Cannara Biotech","article_published_time":"2024-02-08T09:37:00+00:00","article_modified_time":"2024-11-16T21:36:17+00:00","og_image":[{"width":1000,"height":563,"url":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/11\/CannaraPress_Newsdirect-100.jpg","type":"image\/jpeg"}],"author":"cannaraadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"cannaraadmin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/#article","isPartOf":{"@id":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/"},"author":{"name":"cannaraadmin","@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/person\/3aaaabd90bd805cac77b57ae47bf0f91"},"headline":"Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d&rsquo;avenir","datePublished":"2024-02-08T09:37:00+00:00","dateModified":"2024-11-16T21:36:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/"},"wordCount":136,"commentCount":0,"publisher":{"@id":"https:\/\/www.cannara.ca\/fr\/#organization"},"image":{"@id":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/11\/CannaraPress_Newsdirect-100.jpg","articleSection":["Non classifi\u00e9(e)"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/","url":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/","name":"Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d'avenir - Cannara Biotech","isPartOf":{"@id":"https:\/\/www.cannara.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/#primaryimage"},"image":{"@id":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/11\/CannaraPress_Newsdirect-100.jpg","datePublished":"2024-02-08T09:37:00+00:00","dateModified":"2024-11-16T21:36:17+00:00","breadcrumb":{"@id":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/#primaryimage","url":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/11\/CannaraPress_Newsdirect-100.jpg","contentUrl":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/11\/CannaraPress_Newsdirect-100.jpg","width":1000,"height":563},{"@type":"BreadcrumbList","@id":"https:\/\/www.cannara.ca\/fr\/2024\/02\/08\/nicholas-sosiak-directeur-financier-de-cannara-biotech-devoile-ses-strategies-de-reussite-et-ses-projets-davenir\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cannara.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Nicholas Sosiak, directeur financier de Cannara Biotech, d\u00e9voile ses strat\u00e9gies de r\u00e9ussite et ses projets d&#8217;avenir"}]},{"@type":"WebSite","@id":"https:\/\/www.cannara.ca\/fr\/#website","url":"https:\/\/www.cannara.ca\/fr\/","name":"Cannara Biotech","description":"Premium Quality Cannabis","publisher":{"@id":"https:\/\/www.cannara.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cannara.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cannara.ca\/fr\/#organization","name":"Cannara Biotech","url":"https:\/\/www.cannara.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/10\/Cannara_LogoV1_500pxT.png","contentUrl":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/10\/Cannara_LogoV1_500pxT.png","width":500,"height":135,"caption":"Cannara Biotech"},"image":{"@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/person\/3aaaabd90bd805cac77b57ae47bf0f91","name":"cannaraadmin","sameAs":["https:\/\/www.cannara.ca"],"url":"https:\/\/www.cannara.ca\/fr\/author\/cannaraadmin\/"}]}},"jetpack_featured_media_url":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/11\/CannaraPress_Newsdirect-100.jpg","_links":{"self":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/posts\/1075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/comments?post=1075"}],"version-history":[{"count":0,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/posts\/1075\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/media\/1133"}],"wp:attachment":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/media?parent=1075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/categories?post=1075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/tags?post=1075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}